LUNG
Pulmonx Corp
NASDAQ: LUNG · HEALTHCARE · MEDICAL DEVICES
$1.28
+6.67% today
Updated 2026-04-30
Market cap
$54.06M
P/E ratio
—
P/S ratio
0.60x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$1 – $5
Volume
0.6M
Pulmonx Corp (LUNG) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+17.1%
Last 4 quarters
Revenue YoY growth
-4.9%
Most recent quarter
EPS YoY growth
+24.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-23.9%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-0.25 | +36.7% | $1.51 | $1.64 | +8.6% |
| 2025-11-12 | $-0.34 | +19.0% | $2.09 | $1.59 | -23.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.39 | $-0.25 | +36.7% | $22.60M | -4.9% |
| 2025-09-30 | $-0.42 | $-0.34 | +19.0% | $21.50M | +5.5% |
| 2025-06-30 | $-0.39 | $-0.38 | +3.6% | $23.86M | +14.8% |
| 2025-03-31 | $-0.40 | $-0.36 | +8.9% | $22.54M | +19.5% |
| 2024-12-31 | $-0.45 | $-0.33 | +26.7% | $23.77M | +23.3% |
| 2024-09-30 | $-0.45 | $-0.36 | +20.0% | $20.39M | +15.4% |
| 2024-06-30 | $-0.43 | $-0.35 | +18.6% | $20.78M | +20.9% |
| 2024-03-31 | $-0.46 | $-0.36 | +21.7% | $18.85M | +29.7% |
| 2023-12-31 | $-0.41 | $-0.36 | +12.2% | $19.28M | — |
| 2023-09-30 | $-0.43 | $-0.39 | +9.3% | $17.67M | — |
| 2023-06-30 | $-0.44 | $-0.43 | +2.3% | $17.19M | — |
| 2023-03-31 | $-0.44 | $-0.42 | +4.5% | $14.54M | — |
Frequently asked questions
Has Pulmonx Corp beaten earnings estimates?
Pulmonx Corp has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +17.1% over the last 4 quarters.
How does LUNG stock react to earnings?
LUNG stock has moved an average of -7.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Pulmonx Corp's revenue growth rate?
Pulmonx Corp reported year-over-year revenue growth of -4.9% in its most recent quarter, with EPS growing +24.2% year-over-year.